MENU
+Compare
SLRN
Stock ticker: NASDAQ
AS OF
Apr 2, 04:59 PM (EDT)
Price
$2.74
Change
+$0.23 (+9.16%)
Capitalization
275.95M

SLRN ACELYRIN Forecast, Technical & Fundamental Analysis

Acelyrin Inc is a late-stage clinical biopharmaceutical company... Show more

SLRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SLRN with price predictions
Apr 01, 2025

SLRN's RSI Oscillator recovers from overbought zone

The 10-day RSI Indicator for SLRN moved out of overbought territory on March 04, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 10 instances where the indicator moved out of the overbought zone. In of the 10 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SLRN as a result. In of 32 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SLRN turned negative on March 24, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 15 similar instances when the indicator turned negative. In of the 15 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SLRN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The 10-day moving average for SLRN crossed bullishly above the 50-day moving average on March 03, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 4 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SLRN advanced for three days, in of 90 cases, the price rose further within the following month. The odds of a continued upward trend are .

SLRN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 43 cases where SLRN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.602) is normal, around the industry mean (13.458). P/E Ratio (0.000) is within average values for comparable stocks, (64.587). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.867). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (251.391).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SLRN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SLRN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
SLRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SLRN is expected to report earnings to rise 42.83% to -126 cents per share on June 12

ACELYRIN SLRN Stock Earnings Reports
Q1'25
Est.
$-1.27
Q4'24
Beat
by $0.52
Q3'24
Beat
by $0.70
Q2'24
Beat
by $0.22
Q1'24
Beat
by $0.65
The last earnings report on March 27 showed earnings per share of -88 cents, beating the estimate of -140 cents. With 2.66M shares outstanding, the current market capitalization sits at 275.94M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
4149 Liberty Canyon Road
Phone
+1 805 730-0360
Employees
130
Web
https://www.acelyrin.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NSGAX20.39N/A
N/A
Columbia Select Large Cap Equity A
JBAVX28.05N/A
N/A
JHancock Balanced R5
WSMCX14.27N/A
N/A
Allspring Small Company Growth C
LSVFX10.69N/A
N/A
LSV Global Managed Volatility Instl
TLACX10.58N/A
N/A
Transamerica Large Core ESG A

SLRN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SLRN has been loosely correlated with CMND. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if SLRN jumps, then CMND could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLRN
1D Price
Change %
SLRN100%
+1.62%
CMND - SLRN
38%
Loosely correlated
-0.48%
THAR - SLRN
36%
Loosely correlated
-5.88%
SGMT - SLRN
33%
Loosely correlated
-20.86%
OLMA - SLRN
33%
Poorly correlated
-11.17%
GBIO - SLRN
31%
Poorly correlated
-9.11%
More